Asia-Pacific Durable Drug Eluting Stents Market Report 2017

  • KMI167851
  • Sep 2017
  • 129 pages
  • Medical Devices
In this report, the Asia-Pacific Durable Drug Eluting Stents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Durable Drug Eluting Stents for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Durable Drug Eluting Stents market competition by top manufacturers/players, with Durable Drug Eluting Stents sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Boston Scientific
Cordis
Abbott
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Translumina
Vascular Concepts
JW Medical Systems
Kinhely
Lepu Medical
Medfavour Medical

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Polymer Drug Eluting Stents

Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Durable Drug Eluting Stents for each application, includin
Coronary Heart Disease
Clinical

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Asia-Pacific Durable Drug Eluting Stents Market Report 2017
1 Durable Drug Eluting Stents Overview
1.1 Product Overview and Scope of Durable Drug Eluting Stents
1.2 Classification of Durable Drug Eluting Stents by Product Category
1.2.1 Asia-Pacific Durable Drug Eluting Stents Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Durable Drug Eluting Stents Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Polymer Drug Eluting Stents

1.2.4 Other
1.3 Asia-Pacific Durable Drug Eluting Stents Market by Application/End Users
1.3.1 Asia-Pacific Durable Drug Eluting Stents Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Coronary Heart Disease
1.3.3 Clinical
1.4 Asia-Pacific Durable Drug Eluting Stents Market by Region
1.4.1 Asia-Pacific Durable Drug Eluting Stents Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Durable Drug Eluting Stents (2012-2022)
1.5.1 Asia-Pacific Durable Drug Eluting Stents Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Durable Drug Eluting Stents Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Durable Drug Eluting Stents Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Durable Drug Eluting Stents Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Durable Drug Eluting Stents Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Durable Drug Eluting Stents Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Durable Drug Eluting Stents (Volume and Value) by Type
2.2.1 Asia-Pacific Durable Drug Eluting Stents Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Durable Drug Eluting Stents Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Durable Drug Eluting Stents (Volume) by Application
2.4 Asia-Pacific Durable Drug Eluting Stents (Volume and Value) by Region
2.4.1 Asia-Pacific Durable Drug Eluting Stents Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Durable Drug Eluting Stents Revenue and Market Share by Region (2012-2017)

3 China Durable Drug Eluting Stents (Volume, Value and Sales Price)
3.1 China Durable Drug Eluting Stents Sales and Value (2012-2017)
3.1.1 China Durable Drug Eluting Stents Sales Volume and Growth Rate (2012-2017)
3.1.2 China Durable Drug Eluting Stents Revenue and Growth Rate (2012-2017)
3.1.3 China Durable Drug Eluting Stents Sales Price Trend (2012-2017)
3.2 China Durable Drug Eluting Stents Sales Volume and Market Share by Type
3.3 China Durable Drug Eluting Stents Sales Volume and Market Share by Application

4 Japan Durable Drug Eluting Stents (Volume, Value and Sales Price)
4.1 Japan Durable Drug Eluting Stents Sales and Value (2012-2017)
4.1.1 Japan Durable Drug Eluting Stents Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Durable Drug Eluting Stents Revenue and Growth Rate (2012-2017)
4.1.3 Japan Durable Drug Eluting Stents Sales Price Trend (2012-2017)
4.2 Japan Durable Drug Eluting Stents Sales Volume and Market Share by Type
4.3 Japan Durable Drug Eluting Stents Sales Volume and Market Share by Application

5 South Korea Durable Drug Eluting Stents (Volume, Value and Sales Price)
5.1 South Korea Durable Drug Eluting Stents Sales and Value (2012-2017)
5.1.1 South Korea Durable Drug Eluting Stents Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Durable Drug Eluting Stents Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Durable Drug Eluting Stents Sales Price Trend (2012-2017)
5.2 South Korea Durable Drug Eluting Stents Sales Volume and Market Share by Type
5.3 South Korea Durable Drug Eluting Stents Sales Volume and Market Share by Application

6 Taiwan Durable Drug Eluting Stents (Volume, Value and Sales Price)
6.1 Taiwan Durable Drug Eluting Stents Sales and Value (2012-2017)
6.1.1 Taiwan Durable Drug Eluting Stents Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Durable Drug Eluting Stents Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Durable Drug Eluting Stents Sales Price Trend (2012-2017)
6.2 Taiwan Durable Drug Eluting Stents Sales Volume and Market Share by Type
6.3 Taiwan Durable Drug Eluting Stents Sales Volume and Market Share by Application

7 India Durable Drug Eluting Stents (Volume, Value and Sales Price)
7.1 India Durable Drug Eluting Stents Sales and Value (2012-2017)
7.1.1 India Durable Drug Eluting Stents Sales Volume and Growth Rate (2012-2017)
7.1.2 India Durable Drug Eluting Stents Revenue and Growth Rate (2012-2017)
7.1.3 India Durable Drug Eluting Stents Sales Price Trend (2012-2017)
7.2 India Durable Drug Eluting Stents Sales Volume and Market Share by Type
7.3 India Durable Drug Eluting Stents Sales Volume and Market Share by Application

8 Southeast Asia Durable Drug Eluting Stents (Volume, Value and Sales Price)
8.1 Southeast Asia Durable Drug Eluting Stents Sales and Value (2012-2017)
8.1.1 Southeast Asia Durable Drug Eluting Stents Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia Durable Drug Eluting Stents Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia Durable Drug Eluting Stents Sales Price Trend (2012-2017)
8.2 Southeast Asia Durable Drug Eluting Stents Sales Volume and Market Share by Type
8.3 Southeast Asia Durable Drug Eluting Stents Sales Volume and Market Share by Application

9 Australia Durable Drug Eluting Stents (Volume, Value and Sales Price)
9.1 Australia Durable Drug Eluting Stents Sales and Value (2012-2017)
9.1.1 Australia Durable Drug Eluting Stents Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia Durable Drug Eluting Stents Revenue and Growth Rate (2012-2017)
9.1.3 Australia Durable Drug Eluting Stents Sales Price Trend (2012-2017)
9.2 Australia Durable Drug Eluting Stents Sales Volume and Market Share by Type
9.3 Australia Durable Drug Eluting Stents Sales Volume and Market Share by Application

10 Asia-Pacific Durable Drug Eluting Stents Players/Suppliers Profiles and Sales Data
10.1 Boston Scientific
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Durable Drug Eluting Stents Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Boston Scientific Durable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Cordis
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Durable Drug Eluting Stents Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Cordis Durable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Abbott
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Durable Drug Eluting Stents Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Abbott Durable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Advantec Vascular
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Durable Drug Eluting Stents Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Advantec Vascular Durable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 B.Braun Melsengen AG
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Durable Drug Eluting Stents Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 B.Braun Melsengen AG Durable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Biosensors
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Durable Drug Eluting Stents Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Biosensors Durable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Biotronik
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Durable Drug Eluting Stents Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Biotronik Durable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Blue Medical
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Durable Drug Eluting Stents Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Blue Medical Durable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 DISA Vascular
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Durable Drug Eluting Stents Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 DISA Vascular Durable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Essen
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Durable Drug Eluting Stents Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Essen Durable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Medtronic Vascular
10.12 MicroPort Medical
10.13 MIV Therapeutics
10.14 Orbusneich
10.15 Promed Medical
10.16 Relisys Medical
10.17 Reva Medical
10.18 Sahajanand
10.19 Sino Medical
10.20 Sorin
10.21 Terumo Medical
10.22 Translumina
10.23 Vascular Concepts
10.24 JW Medical Systems
10.25 Kinhely
10.26 Lepu Medical
10.27 Medfavour Medical

11 Durable Drug Eluting Stents Manufacturing Cost Analysis
11.1 Durable Drug Eluting Stents Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Durable Drug Eluting Stents

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Durable Drug Eluting Stents Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Durable Drug Eluting Stents Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Durable Drug Eluting Stents Market Forecast (2017-2022)
15.1 Asia-Pacific Durable Drug Eluting Stents Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific Durable Drug Eluting Stents Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific Durable Drug Eluting Stents Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific Durable Drug Eluting Stents Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Durable Drug Eluting Stents Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific Durable Drug Eluting Stents Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific Durable Drug Eluting Stents Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China Durable Drug Eluting Stents Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan Durable Drug Eluting Stents Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea Durable Drug Eluting Stents Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan Durable Drug Eluting Stents Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India Durable Drug Eluting Stents Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia Durable Drug Eluting Stents Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia Durable Drug Eluting Stents Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Durable Drug Eluting Stents Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific Durable Drug Eluting Stents Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific Durable Drug Eluting Stents Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific Durable Drug Eluting Stents Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Durable Drug Eluting Stents Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer


Purchase this Market Research Report



Contact Us


Mannan
Mannan Shaikh
Domain Head
Business Development
+1 (650) 461-4455 (US)
mansing
Mansingh Surve
Manager
Business Development
+1 (888) 278-7681(US)
Vivek
Vivek Pandey
Assistant Manager
Business Development
+1 (888) 278-7681(US)
view